Nordion Inc(USA)  

(Public, NYSE:NDZ)   Watch this stock  
Find more results for NYSE:MDZ
Aug 6 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 7.27 - 13.01
Open     -
Vol / Avg. 0.00/520,221.00
Mkt cap 804.20M
P/E 2.89
Div/yield     -
EPS 4.50
Shares 61.91M
Beta 0.52
Inst. own 85%

Key stats and ratios

Q2 (Apr '14) 2013
Net profit margin 8.97% 101.87%
Operating margin 13.46% 94.80%
EBITD margin - 11.34%
Return on average assets 4.35% 45.36%
Return on average equity 5.70% 72.49%
Employees 411 -
CDP Score - -


447 March Rd.
+1-613-5922790 (Phone)
+1-613-5926937 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Nordion Inc. (Nordion), is a global health science company. The Company is engaged in products and services used for the prevention, diagnosis and treatment of disease. The Company operates one business unit, Specialty Isotopes. It operates in two segments: Sterilization Technologies and Medical Isotopes. On July 13, 2013, Nordion completed the sale of its Targeted Therapies business to BTG, an international specialist healthcare company based in London, United Kingdom. In August 2014, the Company announced that it has completed the plan of arrangement and all of the outstanding common shares of Nordion Inc have been acquired by an affiliate of Sterigenics International LLC. Effective August 6, 2014, Sterigenics International Inc, a unit of GTCR LLC, acquired the entire share capital of Nordion Inc.